Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
While GLP-1 drugs may offer neuroprotective effects relevant to glaucoma, the impact of dual-incretin therapies like tirzepatide on glaucoma remains unknown
Clinically, this would lead to unpredictable results, with the day-to-day efficacy of the supplement varying wildly with the food consumed by the patient
It also states that most providers currently advise against the combination
In terms of outcomes, studies show that semaglutide users typically lose between 6 to 10 kilograms, while tirzepatide users may lose between 7 to 13 kilograms
You can also use the CDCs BMI calculator here
US$ 28.16
US$ 29.54
US$ 20.17
US$ 27.30
US$ 22.68
US$ 20.27
US$ 21.27
US$ 26.89
